title: In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum.
abstract: IgG anti-filaggrin autoantibodies (AFA) are the most specific serological markers of rheumatoid arthritis (RA). They include the so-called 'anti-keratin antibodies' (AKA) and anti-perinuclear factor (APF), and recognize human epidermal filaggrin and other (pro)filaggrin-related proteins of various epithelial tissues. In this study we demonstrate that AFA are produced in rheumatoid synovial joints. In 31 RA patients, AFA levels were assayed at equal IgG concentrations in paired synovial fluids (SF) and sera. AFA titre-like values determined by indirect immunofluorescence and immunoblotting and AFA concentrations determined by ELISA were non-significantly different in serum and SF, clearly indicating that AFA are not concentrated in SF. In contrast, we demonstrated that AFA are enriched in RA synovial membranes, since the ELISA-determined AFA in low ionic-strength extracts of synovial tissue from four RA patients represented a 7.5-fold higher proportion of total IgG than in paired sera. When small synovial tissue explants from RA patients were cultured for a period of 5 weeks, the profile of IgG and AFA released in the culture supernatants was first consistent with passive diffusion of the tissue-infiltrating IgG (including AFA) over the first day of culture, then with a de novo synthesis of IgG and AFA. Therefore, AFA-secreting plasma cells are present in the synovial tissue of RA patients and AFA can represent a significant proportion of the IgG secreted within the rheumatoid pannus.
authors.affiliation: Department of Biology and Pathology of the Cell, Institut National de la Santé et de la Recherche Médicale (CJF 96-02), Toulouse-Purpan School of Medicine, University of Toulouse III, France.
authors.forename: C
authors.initials: C
authors.lastname: Masson-Bessière
authors.forename: M
authors.initials: M
authors.lastname: Sebbag
authors.forename: J J
authors.initials: JJ
authors.lastname: Durieux
authors.forename: L
authors.initials: L
authors.lastname: Nogueira
authors.forename: C
authors.initials: C
authors.lastname: Vincent
authors.forename: E
authors.initials: E
authors.lastname: Girbal-Neuhauser
authors.forename: R
authors.initials: R
authors.lastname: Durroux
authors.forename: A
authors.initials: A
authors.lastname: Cantagrel
authors.forename: G
authors.initials: G
authors.lastname: Serre
mesh_terms: D001172:Arthritis, Rheumatoid / Q000097:blood / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D015415:Biomarkers; D004817:Epidermis / Q000276:immunology / Q000473:pathology; D000091344:Filaggrin Proteins; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D007381:Intermediate Filament Proteins / Q000276:immunology*; D010950:Plasma Cells / Q000276:immunology* / Q000473:pathology; D013582:Synovial Fluid / Q000276:immunology
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; C000717249:FLG protein, human; D000091344:Filaggrin Proteins; D007074:Immunoglobulin G; D007381:Intermediate Filament Proteins